Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines (Q37895394)

24 August 2017

1 reference

title

Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines (English)

1 reference

24 August 2017

0 references

Lars Eckardt

1 reference

24 August 2017

Kristina Wasmer

1 reference

24 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21712281

5 December 2024

publication date

28 June 2011

1 reference

full work available at URL

24 August 2017

published in

EP Europace

1 reference

24 August 2017

1 reference

24 August 2017

1 reference

24 August 2017

page(s)

1368-1374

1 reference

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Etiology and Initial Investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Management of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Catheter Ablation for Atrial Fibrillation/Atrial Flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Surgical Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention and Treatment of Atrial Fibrillation Following Cardiac Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Validation of Clinical Classification Schemes for Predicting Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

The 2010 Update of the ESC Guidelines for the Management of Atrial Fibrillation - Beyond the Rate or Rhythm Strategy Debate -

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Independent predictors of stroke in patients with atrial fibrillation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Rhythm control versus rate control for atrial fibrillation and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Lenient versus strict rate control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Effect of dronedarone on cardiovascular events in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Increased mortality after dronedarone therapy for severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Implementing GRADE and Achieving Consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR172

Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data

21 January 2018

1 reference

10.1093/EUROPACE/EUR172

https://api.crossref.org/works/10.1093/EUROPACE/EUR172

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation

5 December 2024

1 reference

10.1093/EUROPACE/EUR172

https://api.crossref.org/works/10.1093/EUROPACE/EUR172

5 December 2024

Identifiers

DOI

10.1093/EUROPACE/EUR172

1 reference

24 August 2017

1 reference